TN2015000335A1 - Vortioxetine manufacturing process - Google Patents

Vortioxetine manufacturing process

Info

Publication number
TN2015000335A1
TN2015000335A1 TN2015000335A TN2015000335A TN2015000335A1 TN 2015000335 A1 TN2015000335 A1 TN 2015000335A1 TN 2015000335 A TN2015000335 A TN 2015000335A TN 2015000335 A TN2015000335 A TN 2015000335A TN 2015000335 A1 TN2015000335 A1 TN 2015000335A1
Authority
TN
Tunisia
Prior art keywords
vortioxetine
manufacturing process
dimethylthiophenol
decomplexation
ate
Prior art date
Application number
TN2015000335A
Other languages
English (en)
Inventor
Thomas Ruhland
Kim Lasse Christensen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of TN2015000335A1 publication Critical patent/TN2015000335A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
TN2015000335A 2013-02-22 2015-08-06 Vortioxetine manufacturing process TN2015000335A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361767883P 2013-02-22 2013-02-22
DKPA201300104 2013-02-22
PCT/EP2014/053313 WO2014128207A1 (en) 2013-02-22 2014-02-20 Vortioxetine manufacturing process

Publications (1)

Publication Number Publication Date
TN2015000335A1 true TN2015000335A1 (en) 2017-01-03

Family

ID=59215387

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2015000335A TN2015000335A1 (en) 2013-02-22 2015-08-06 Vortioxetine manufacturing process

Country Status (37)

Country Link
US (1) US9353073B2 (enExample)
EP (1) EP2958903B1 (enExample)
JP (1) JP6464098B2 (enExample)
KR (1) KR102230628B1 (enExample)
CN (1) CN104995181B (enExample)
AP (1) AP2015008640A0 (enExample)
AU (1) AU2014220735B2 (enExample)
BR (1) BR112015019268B1 (enExample)
CA (1) CA2901821A1 (enExample)
CL (1) CL2015002309A1 (enExample)
CR (1) CR20150423A (enExample)
CY (1) CY1118883T1 (enExample)
DK (1) DK2958903T3 (enExample)
DO (1) DOP2015000187A (enExample)
EA (1) EA027756B1 (enExample)
ES (1) ES2625380T3 (enExample)
GE (1) GEP201706749B (enExample)
HR (1) HRP20170607T1 (enExample)
IL (1) IL240501B (enExample)
LT (1) LT2958903T (enExample)
MA (1) MA38338B1 (enExample)
ME (1) ME02671B (enExample)
MX (1) MX362355B (enExample)
MY (1) MY172337A (enExample)
PE (1) PE20151589A1 (enExample)
PH (1) PH12015501807B1 (enExample)
PL (1) PL2958903T3 (enExample)
PT (1) PT2958903T (enExample)
RS (1) RS55932B1 (enExample)
RU (1) RU2652265C2 (enExample)
SG (1) SG11201506651SA (enExample)
SI (1) SI2958903T1 (enExample)
SM (1) SMT201700238T1 (enExample)
TN (1) TN2015000335A1 (enExample)
UA (1) UA116236C2 (enExample)
WO (1) WO2014128207A1 (enExample)
ZA (1) ZA201506050B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2605652B1 (en) 2010-08-18 2017-11-08 Samumed, LLC Diketones and hydroxyketones as catenin signaling pathway activators
ES2709824T3 (es) 2013-02-22 2019-04-17 Samumed Llc Gamma-dicetonas como activadores de la ruta de señalización Wnt/beta-catenina
DK3206686T3 (da) 2014-08-20 2019-12-16 Samumed Llc Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker
WO2016125191A2 (en) 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide
EP3274330A1 (en) 2015-03-26 2018-01-31 Cipla Limited Method for making serotonin reuptake inhibitors
CN106279065A (zh) * 2015-05-12 2017-01-04 北京深蓝海生物医药科技有限公司 一种氢溴酸沃替西汀的精制转晶方法
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
EP3414216B1 (en) * 2016-02-08 2020-10-21 AAA Chemistry ApS Arylation of aliphatic amines
JP2019524682A (ja) 2016-07-01 2019-09-05 ハー・ルンドベック・アクチエゼルスカベット 抗うつ作用の速い発現のためのボルチオキセチン投与計画
US10519121B2 (en) 2016-12-30 2019-12-31 Apicore Us Llc Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
EP3870292A4 (en) 2018-10-26 2022-11-09 The Research Foundation for The State University of New York COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
CN109912538B (zh) * 2019-01-22 2021-03-12 安徽赛乐普制药有限公司 一种抗抑郁药沃替西汀的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
MXPA04005989A (es) * 2001-12-20 2004-09-27 Lundbeck & Co As H Derivados de ariloxifenilo y arilsulfanilfenilo.
KR20090028712A (ko) * 2006-06-16 2009-03-19 하. 룬트벡 아크티에 셀스카브 인지기능 장애의 치료를 위한, 세로토닌 재흡수, 5-ht3 및 5-ht1a 활성이 조합된 화합물로서의 1-[2-(2,4-디메틸페닐술파닐)-페닐]피페라진
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine

Also Published As

Publication number Publication date
RU2015134407A (ru) 2017-03-28
IL240501B (en) 2018-08-30
IL240501A0 (en) 2015-09-24
EA201591349A1 (ru) 2015-12-30
PE20151589A1 (es) 2015-12-03
PL2958903T3 (pl) 2017-08-31
RU2652265C2 (ru) 2018-04-27
WO2014128207A1 (en) 2014-08-28
SMT201700238T1 (it) 2017-07-18
MX362355B (es) 2019-01-14
HK1216098A1 (en) 2016-10-14
CL2015002309A1 (es) 2016-03-04
CR20150423A (es) 2015-10-20
US20160009670A1 (en) 2016-01-14
ES2625380T3 (es) 2017-07-19
CN104995181B (zh) 2017-03-08
PH12015501807B1 (en) 2019-05-31
MY172337A (en) 2019-11-21
US9353073B2 (en) 2016-05-31
EP2958903A1 (en) 2015-12-30
ME02671B (me) 2017-06-20
JP2016509042A (ja) 2016-03-24
BR112015019268B1 (pt) 2023-01-10
LT2958903T (lt) 2017-08-25
MX2015010656A (es) 2015-12-17
AU2014220735A1 (en) 2015-08-20
DOP2015000187A (es) 2015-11-30
HRP20170607T1 (hr) 2017-06-30
EA027756B1 (ru) 2017-08-31
PT2958903T (pt) 2017-05-26
RS55932B1 (sr) 2017-09-29
AP2015008640A0 (en) 2015-08-31
CN104995181A (zh) 2015-10-21
EP2958903B1 (en) 2017-04-12
DK2958903T3 (en) 2017-05-15
MA38338A1 (fr) 2016-09-30
KR20150118146A (ko) 2015-10-21
SI2958903T1 (sl) 2017-09-29
SG11201506651SA (en) 2015-09-29
JP6464098B2 (ja) 2019-02-06
MA38338B1 (fr) 2018-10-31
AU2014220735B2 (en) 2017-06-22
GEP201706749B (en) 2017-10-10
CY1118883T1 (el) 2018-01-10
BR112015019268A2 (pt) 2020-01-28
KR102230628B1 (ko) 2021-03-22
UA116236C2 (uk) 2018-02-26
ZA201506050B (en) 2017-08-30
CA2901821A1 (en) 2014-08-28
PH12015501807A1 (en) 2015-11-09

Similar Documents

Publication Publication Date Title
TN2015000335A1 (en) Vortioxetine manufacturing process
UA113643C2 (xx) N-цикліламіди як нематоциди
MY182082A (en) Biheteroaryl compounds and uses thereof
IN2012DE00621A (enExample)
MY199066A (en) Processes for producing diazabicyclooctane compounds
WO2015008218A3 (en) Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant
IN2012DE00620A (enExample)
IN2013MU00646A (enExample)
IN2014DN09053A (enExample)
MX2016001641A (es) Ciclobutilcarboxamidas como nematicidas.
AU2014371081A1 (en) Polyoxalates and a Process for the Production Thereof
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
MX2016005223A (es) Tinturas dispersas, su preparacion y su uso.
CR20160165A (es) Acetato de 4-{4-[(1 e)-4-(2,9- diazaespiro [5.5] undec-2-il) but-1 -en-i -il]-2- metilbencil}-5-(propan-2-il) -1h-pirazol-3-ilo beta-d- glucopiranósido
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
MX2016000487A (es) Piridina-2-carboxamidas como nematicidas.
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
MX2016005219A (es) Tinturas acidas, proceso para su produccion y su uso.
IN2014DE01203A (enExample)
MX2016005220A (es) Tinturas acidas, proceso para su produccion y su uso.
MX2016005222A (es) Tinturas acidas, proceso para su produccion y su uso.
ECSP15036884A (es) Proceso de fabricación de vortioxetina
UA87254U (ru) Соединение 1,1-диэтилкарбокси-2-метокси-2-трифторметилэтилен с потенциальными физиологическими свойствами
UA89447U (ru) Соединение 1,1-диэтилкарбокси-2-хлор-2-трифторметилэтилен с потенциальными физиологическими свойствами
UA87694U (uk) Сполука 4,5,6,7-тетрагідро-3н-2-n-(пара-метоксифенациламіно)-азепіну гідрохлорид з потенційними фізіологічними властивостями